Temporal changes in the number of European and American guideline recommendations and underlying evidence base for the management of infective: An update of previous published data

IF 3.7 2区医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

American heart journal Pub Date : 2024-06-10 DOI:10.1016/j.ahj.2024.04.014

Lauge Østergaard MD, PhD, Sofie Truong MB, Jeppe Petersen MD, Eva Havers-Borgersen MD, Lars Køber MD, DMSc, Emil Loldrup Fosbøl MD, PhD

引用次数: 0

Abstract

This report aimed to examine temporal changes in the number of recommendations on management of infective endocarditis in the European and American guidelines. The number of recommendations has increased since 2004 without an increment in evidence base in the European iteration. American guidelines have reduced the number of recommendations with a main evidence base of level B.

查看原文本刊更多论文

欧洲和美国关于感染性疾病管理的指南建议数量和基本证据基础的时间变化：更新以往公布的数据

本报告旨在研究欧洲和美国指南中有关感染性心内膜炎管理建议数量的时间变化。自 2004 年以来，欧洲指南中的建议数量有所增加，但证据基础没有增加。美国指南减少了主要证据基础为B级的建议数量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American heart journal 医学-心血管系统

CiteScore

8.20

自引率

2.10%

发文量

214

审稿时长

38 days

期刊介绍： The American Heart Journal will consider for publication suitable articles on topics pertaining to the broad discipline of cardiovascular disease. Our goal is to provide the reader primary investigation, scholarly review, and opinion concerning the practice of cardiovascular medicine. We especially encourage submission of 3 types of reports that are not frequently seen in cardiovascular journals: negative clinical studies, reports on study designs, and studies involving the organization of medical care. The Journal does not accept individual case reports or original articles involving bench laboratory or animal research.